Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.47 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 7/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | ATM | Q13315 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5252788 | 0.95 | PGR (0.46) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL8471027 | 0.93 | PGR (0.45) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL8473579 | 0.93 | PGR (0.45) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL11170402 | 0.90 | PGR (0.52) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL8733899 | 0.85 | PGR (0.51) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL4994418 | 0.85 | PGR (0.51) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL6424289 | 0.84 | CES2 (0.50) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL5252785 | 0.84 | PGR (0.46) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL24896949 | 0.82 | HDAC1 (0.53) | PGRADRA2AADRA2BHTR2AHRH1 | |
| SCHEMBL6684015 | 0.82 | CES2 (0.51) | PGRADRA2AADRA2BHTR2AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9757493-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2017-09-12 | — | — | US | claimed |
| US-20160250376-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | TUTOGEN MEDICAL, INC. | 2016-09-01 | — | — | US | claimed |
| EP-2192886-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | Pioneer Surgical Technology, Inc. (US) | 2010-06-09 | — | — | EP | claimed |
| US-20090270527-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | ANGSTROM MEDICA (US) | 2009-10-29 | — | — | US | claimed |
| WO-2009029734-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2009-03-05 | — | — | WO | claimed |
| US-20250083136-A1 | METHODS AND SYSTEMS FOR MODIFYING SELECTIVITY IN CATALYTIC REACTIONS | U.S. DEPARTMENT OF ENERGY | 2025-03-13 | — | — | US | disclosed |
| CN-111253583-B | Dilatant hybrid dynamic polymer and dilatant realization method thereof | 厦门天策材料科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-108329265-B | Imidazole ion-containing photocuring monomer and application thereof in self-repairing photocuring material | 北京化工大学 | 2020-11-03 | — | — | CN | disclosed |
| US-10799610-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| CN-111253583-A | Dilatancy hybrid dynamic polymer and method for realizing dilatancy thereof | 翁秋梅 | 2020-06-09 | — | — | CN | disclosed |
| CN-111171329-A | Plastic dilatancy polymer and method for realizing dilatancy thereof | 翁秋梅 | 2020-05-19 | — | — | CN | disclosed |
| US-10413632-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| EP-1922052-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | Angstrom Medica, Inc. (US) | 2008-05-21 | — | — | EP | disclosed |
| US-20070293948-A1 | Bioactive Spinal Implants and Method of Manufacture Thereof | VITA SPECIAL PURPOSE CORPORATION | 2007-12-20 | — | — | US | disclosed |
| US-7238203-B2 | Bioactive spinal implants and method of manufacture thereof | VITA SPECIAL PURPOSE CORPORATION (US) | 2007-07-03 | — | — | US | disclosed |
| WO-2007019461-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | ANGSTROM MEDICA, INC. (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20070032568-A1 | Cement products and methods of making and using the same | ANGSTROM MEDICA (US) | 2007-02-08 | — | — | US | disclosed |
| US-6987136-B2 | Bioactive spinal implant material and method of manufacture thereof | VITA SPECIAL PURPOSE CORPORATION (US) | 2006-01-17 | — | — | US | disclosed |
| US-20030125739-A1 | Bioactive spinal implants and method of manufacture thereof | VITA SPECIAL PURPOSE CORP. | 2003-07-03 | — | — | US | disclosed |
| US-20030087984-A1 | Bioactive spinal implant material and method of manufacture thereof | VITA SPECIAL PURPOSE CORP. | 2003-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250083136-A1 | METHODS AND SYSTEMS FOR MODIFYING SELECTIVITY IN CATALYTIC REACTIONS | HMBS, UNG, MPG | PGR 2649/4885ADRA2A 3435/4885ADRA2B 3558/4885 |
| US-20070032568-A1 | Cement products and methods of making and using the same | BMP2, ETF1, EPHX2 | PGR 2357/4885ADRA2A 4214/4885ADRA2B 4229/4885 |
| US-20160250376-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | BHMT2, SHMT1, BHMT | PGR 3040/4885ADRA2A 4698/4885ADRA2B 4716/4885 |
| US-10799610-B2 | Cement products and methods of making and using the same | BHMT2, SHMT1, BHMT | PGR 3040/4885ADRA2A 4698/4885ADRA2B 4716/4885 |
| US-10413632-B2 | Cement products and methods of making and using the same | BHMT2, SHMT1, BHMT | PGR 3040/4885ADRA2A 4698/4885ADRA2B 4716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.